Your browser doesn't support javascript.
loading
Socioeconomic status and quality of multiple sclerosis care in Sweden.
He, Anna; Manouchehrinia, Ali; Glaser, Anna; Butzkueven, Helmut; Ciccarelli, Olga; Hillert, Jan; McKay, Kyla A.
Affiliation
  • He A; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University Coll
  • Manouchehrinia A; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Glaser A; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • Butzkueven H; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia.
  • Ciccarelli O; Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Hillert J; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • McKay KA; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Mult Scler Relat Disord ; 88: 105726, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38936323
ABSTRACT
In Sweden's universal healthcare system, it is unknown whether people of higher socioeconomic status receive higher quality multiple sclerosis (MS) care. Using linked clinical and administrative data, we investigated the quality of care received by 4426 adults aged 23-60 with relapsing-remitting MS. In adjusted analyses, we demonstrated that higher premorbid educational attainment is associated with 4-12 % more frequent neurologist visits and MRI scans in the first four years post diagnosis, while higher premorbid income was associated with faster diagnosis-to-treatment times by 34-64 days. Neither education nor income were associated with time to diagnosis. This suggests that the more favourable MS outcomes observed for people of higher socioeconomic status may in part be related to higher quality care.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Health Care / Social Class / Multiple Sclerosis, Relapsing-Remitting Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Mult Scler Relat Disord Year: 2024 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Health Care / Social Class / Multiple Sclerosis, Relapsing-Remitting Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Mult Scler Relat Disord Year: 2024 Document type: Article Country of publication: Países Bajos